The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population
NCT02614248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149
Last updated 2024-10-15
Summary
The purpose of the study is to examine the safety and effectiveness of the use of coconut oil for the prevention and treatment of diaper dermatitis among NICU babies at Genesis Medical Center, Davenport.
Conditions
- Dermatitis, Contact
Interventions
- OTHER
-
Organic, Unrefined Coconut Oil
- OTHER
-
Medline Remedy Phytoplex Z-Guard Skin Protectant
Sponsors & Collaborators
-
Genesis Health System
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Hours
- Max Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-30
Countries
- United States
Study Locations
More Related Trials
-
Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
NCT02306980 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Probiotics in Neonatal Jaundice
NCT06449508 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
NCT01601847 ·Status: COMPLETED ·Phase: PHASE4
-
Probiotics/TPN in the NICU
NCT04977817 ·Status: COMPLETED
-
Prebiotic in Preterm Infants
NCT03306316 ·Status: COMPLETED ·Phase: NA
-
Oral Care With Colostrum for Preventing Late-onset Sepsis in Preterm Infants
NCT06534632 ·Status: COMPLETED ·Phase: NA
-
Probiotics to Prevent NEC - a Historical Control Study
NCT01670916 ·Status: COMPLETED
-
Efficacy of a Dietary Supplement in Infants
NCT07341477 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children
NCT03183440 ·Status: UNKNOWN ·Phase: NA
-
DHA Proof-of-Concept Study in Infants and Toddlers
NCT05266677 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Addition of Structured Lipids in Starter Formulas
NCT02332967 ·Status: COMPLETED ·Phase: NA
-
Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome
NCT05546814 ·Status: COMPLETED ·Phase: NA
-
Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates
NCT03387579 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Probiotics for Prevention of NEC in Preterm VLBW Infants
NCT02650869 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
NCT03266913 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of the Role of Probiotics in Prevention of Ventilator-Associated Pneumonia in Neonates
NCT07001163 ·Status: COMPLETED ·Phase: NA
-
Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
NCT00005888 ·Status: COMPLETED ·Phase: NA
-
The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants
NCT00593684 ·Status: COMPLETED ·Phase: NA
-
Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
NCT00977912 ·Status: TERMINATED ·Phase: NA
-
Bifidobacterium Supplementation for Very Low Birth Weight Infants
NCT01375309 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
NCT02598817 ·Status: COMPLETED
-
Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation
NCT03346447 ·Status: COMPLETED
-
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
NCT00658905 ·Status: COMPLETED ·Phase: PHASE2
-
Feeding Trial in Pediatric Patients
NCT01469117 ·Status: COMPLETED
-
Lactulose Supplementation in Premature Infants
NCT00616876 ·Status: COMPLETED ·Phase: PHASE2